Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Beats on EPS, Stock Up 4.8%

Arrowhead Pharmaceuticals reported a positive earnings surprise on EPS, which contributed to a 4.8% increase in stock price. However, there was no revenue figure provided, leaving some uncertainty about overall performance. The lack of guidance and management commentary means investors will need to wait for more information to understand the company's future direction.